Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Benchmark Research
The Purpose of Audits: A Look at Developments in the United Kingdom
Below is an excerpt from ISS’ recently released paper “The Purpose of Audits: A Look at Developments in the United Kingdom“. The full paper is available for download from the ISS Governance online library. In May 2018, UK multinational outsourcing giant Carillion collapsed with a calamitous loss of jobs, pensions, and investor value, and plunging hundreds of public sector projects into crisis.
Recent Regulatory Changes in Key MENA Markets Expected to Reshape Corporate Governance
The MENA region’s corporate governance regime is rapidly evolving towards improved application of international best practices, reflecting the growing desire to enhance the region’s competitive edge. These new regulations seek to reinforce competitiveness and increase economic growth through improved corporate governance.
02.06.23 -- Raising Minority Enrollment With Creativity & Collaboration
Welcome to the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. Update your topic preferences to receive additional Clinical Leader newsletters on: Clinical Trial Technology (Tuesday) Decentralized Trials | Trial Management (Wednesday) Outsourcing Models | Regulatory & Compliance (Thursday) (Friday)
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Raising Minority Enrollment With Creativity And Collaboration
By Van R. Johnson, ABA, BA, vice president commercial strategy, Benchmark Research The growing need for increased diversity in clinical trials has been emphasized a great deal over the past few years. But the fact is, it can’t be emphasized enough. The FDA has issued several statements and guidance documents surrounding the importance of a diverse population in clinical trials.
09.12.22 -- FDA's Diversity Plan: 5 Things It Needs To Include
Welcome to the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. Update your topic preferences to receive additional Clinical Leader newsletters on: Clinical Trial Technology (Tuesday) Decentralized Trials | Trial Management (Wednesday) Outsourcing Models | Regulatory & Compliance (Thursday) (Friday)
Summary Background One strategy to develop a universal influenza virus vaccine is to redirect the immune system to the highly conserved haemagglutinin stalk domain by sequentially administering vaccines expressing chimeric (c) haemagglutinins with a conserved stalk domain and divergent head domain, to which humans are naive.
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial - Nature Medicine
Abstract Rising breakthrough infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in previously immunized individuals have raised concerns for the need for a booster vaccine dose to combat waning antibody levels and new variants.
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis - Nature Medicine
Abstract The emergence of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs) with decreased susceptibility to neutralization has generated interest in assessments of booster doses and variant-specific vaccines.
Benchmark Research Recognized as Best Vaccine Developmental Clinical Research Firm
AUSTIN, Texas, May 21, 2021 /PRNewswire-PRWeb/ -- "The success of Benchmark Research may best be shown by the way the US government trusted them during unprecedented circumstances. Their unique knowledge, expertise and skill set made them the ideal partners for Operation Warp Speed.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Benchmark
Contact Benchmark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack